NCT07046507

Brief Summary

This is an exploratory study using anterior segment optical coherence tomography (OCT) devices to measure copper in the eye. The investigators hope to use this to diagnosis kayser flesicher rings, an important diagnostic criteria in Wilson's disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 2, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 12, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 1, 2025

Completed
Last Updated

July 1, 2025

Status Verified

June 1, 2025

Enrollment Period

8 months

First QC Date

May 12, 2025

Last Update Submit

June 23, 2025

Conditions

Keywords

kayser fleischer rings

Outcome Measures

Primary Outcomes (1)

  • Primary outcome

    Can handheld anterior segment optical coherence tomography (OCT) imaging be used as a reliable and practical methodology in the diagnosis/detection of kayser fleischer rings (KFR) in a non-inferior way compared with slit lamp examination and fixed optical coherence tomography. KFR can be visualised on OCT images in a similar way as they are seem on slit lamp examination.

    Baseline examination

Secondary Outcomes (3)

  • Measurement of the amount of copper in the eye

    Baseline examination

  • Is a handheld OCT device non inferior to a fixed OCT device

    Baseline examination

  • Can this test detect Kayser Fleischer rings before current standard of care testing

    Baseline examination

Study Arms (2)

Use of a fixed anterior segment OCT device to detect Kayser Fleischer ring

ACTIVE COMPARATOR
Diagnostic Test: Diagnostic procedures

Use of a handheld anterior segment OCT device to detect Kayser Fleischer rings

ACTIVE COMPARATOR
Diagnostic Test: Diagnostic procedures

Interventions

Diagnostic proceduresDIAGNOSTIC_TEST

Diagnostic ability of optical coherence tomography in kayser fleischer rings

Use of a fixed anterior segment OCT device to detect Kayser Fleischer ringUse of a handheld anterior segment OCT device to detect Kayser Fleischer rings

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Wilson patients with Kayser Fleischer rings on slit lamp examination and 5 patients without Kayser Fleischer rings on slit lamp examination

You may not qualify if:

  • Those who do not have a confirmed diagnosis of Wilson's disease and no previous formal slit lamp examination will be excluded from recruitment.
  • The investigators will also exclude those patients with known corneal disease, history of intraocular disease, haematological disease, pregnancy, and use of topical or intraocular medication.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Surrey Country Hospital

London, United Kingdom

Location

MeSH Terms

Conditions

Hepatolenticular Degeneration

Interventions

Diagnostic Techniques and Procedures

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolism, Inborn ErrorsMetal Metabolism, Inborn ErrorsMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diagnosis

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessors blinded to patient groups
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: Non-inferiority exploratory study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 12, 2025

First Posted

July 1, 2025

Study Start

August 2, 2024

Primary Completion

March 31, 2025

Study Completion

April 1, 2025

Last Updated

July 1, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Not appropriate

Locations